HERVOLUTION Trademark

Trademark Overview


On Tuesday, February 6, 2024, a trademark application was filed for HERVOLUTION with the United States Patent and Trademark Office. The USPTO has given the HERVOLUTION trademark a serial number of 98393796. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 20, 2025. This trademark is owned by InProTher ApS. The HERVOLUTION trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for treating immune diseases and cancer; Substances adapted for medical or veterinary use, namely pharmaceutical preparations for treating immune diseases and cancer; Vaccines and medicines for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline; Viral-based immunotherapeutics being pharmaceutical preparations, in particular for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and ALS, and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline

Business management, organization and administration; business management of licences for pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; import and export agency services in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; retail store and wholescale store services, and online retail store and wholesale store services, in the field of pharmaceuticals, vaccines and medicines, such as viral- based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases

Research and development of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; conducting clinical trials of others in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; medical, biological, and scientific research relating to the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases, in particular via immunotherapy
hervolution

General Information


Serial Number98393796
Word MarkHERVOLUTION
Filing DateTuesday, February 6, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2025

Trademark Statements


Goods and ServicesPharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for treating immune diseases and cancer; Substances adapted for medical or veterinary use, namely pharmaceutical preparations for treating immune diseases and cancer; Vaccines and medicines for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline; Viral-based immunotherapeutics being pharmaceutical preparations, in particular for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and ALS, and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline
Pseudo MarkHER VOLUTION
Goods and ServicesBusiness management, organization and administration; business management of licences for pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; import and export agency services in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; retail store and wholescale store services, and online retail store and wholesale store services, in the field of pharmaceuticals, vaccines and medicines, such as viral- based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases
Goods and ServicesResearch and development of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; conducting clinical trials of others in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; medical, biological, and scientific research relating to the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases, in particular via immunotherapy

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInProTher ApS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCopenhagen 2200
DK

Party NameInProTher ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen 2200
DK

Trademark Events


Event DateEvent Description
Tuesday, June 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 30, 2024NON-FINAL ACTION WRITTEN
Friday, August 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 30, 2024ASSIGNED TO EXAMINER
Friday, August 30, 2024NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2025FINAL REFUSAL E-MAILED
Wednesday, January 22, 2025FINAL REFUSAL WRITTEN
Wednesday, January 22, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 6, 2024NEW APPLICATION ENTERED
Monday, April 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 14, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 20, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 20, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED